139 related articles for article (PubMed ID: 18617764)
1. [Incidence and risk factors of acute renal failure after transcatheter arterial chemoembolization for hepatocellular carcinoma].
Jang BK; Lee SH; Chung WJ; Park KS; Cho KB; Hwang JS; Kim YH; Choi JS; Kwon JH
Korean J Hepatol; 2008 Jun; 14(2):168-77. PubMed ID: 18617764
[TBL] [Abstract][Full Text] [Related]
2. [Incidence and risk factors of acute hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma].
Jeon SH; Park KS; Kim YH; Shin YS; Kang MK; Jang BK; Chung WJ; Cho KB; Hwang JS
Korean J Gastroenterol; 2007 Sep; 50(3):176-82. PubMed ID: 17885283
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study.
Huo TI; Wu JC; Lee PC; Chang FY; Lee SD
Liver Int; 2004 Jun; 24(3):210-5. PubMed ID: 15189271
[TBL] [Abstract][Full Text] [Related]
4. Incidence, risk factors, and prognosis of acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma: a prospective cohort study.
Hao JF; Zhang LW; Bai JX; Li YJ; Liu JN; Zhang XL; Han JM; Li X; Jiang H; Cao N
Indian J Cancer; 2015 Feb; 51 Suppl 2():e3-8. PubMed ID: 25712839
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.
Cho HS; Seo JW; Kang Y; Bae EJ; Kim HJ; Chang SH; Park DJ
Clin Exp Nephrol; 2011 Oct; 15(5):714-719. PubMed ID: 21695415
[TBL] [Abstract][Full Text] [Related]
6. Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization.
Hsu CY; Huang YH; Su CW; Lin HC; Chiang JH; Lee PC; Lee FY; Huo TI; Lee SD
Liver Int; 2010 Jan; 30(1):77-84. PubMed ID: 19818004
[TBL] [Abstract][Full Text] [Related]
7. Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction.
Garwood ER; Fidelman N; Hoch SE; Kerlan RK; Yao FY
Liver Transpl; 2013 Feb; 19(2):164-73. PubMed ID: 23008091
[TBL] [Abstract][Full Text] [Related]
8. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors of transarterial chemoembolisation toxicity in unresectable hepatocellular carcinoma.
Boulin M; Adam H; Guiu B; Aho LS; Cercueil JP; Di Martino C; Fagnoni P; Minello A; Jouve JL; Hillon P; Bedenne L; Lepage C
Dig Liver Dis; 2014 Apr; 46(4):358-62. PubMed ID: 24462550
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors of contrast-induced nephropathy after transcatheter arterial chemoembolization in hepatocellular carcinoma.
Aoe M; Kanemitsu T; Ohki T; Kishi S; Ogura Y; Takenaka Y; Hashiba T; Ambe H; Furukawa E; Kurata Y; Ichikawa M; Ohara K; Honda T; Furuse S; Saito K; Toda N; Mise N
Clin Exp Nephrol; 2019 Sep; 23(9):1141-1146. PubMed ID: 31183589
[TBL] [Abstract][Full Text] [Related]
11. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome.
Huo TI; Wu JC; Huang YH; Chiang JH; Lee PC; Chang FY; Lee SD
Aliment Pharmacol Ther; 2004 May; 19(9):999-1007. PubMed ID: 15113367
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiency.
Hsu CY; Huang YH; Su CW; Chiang JH; Lin HC; Lee PC; Lee FY; Huo TI; Lee SD
J Clin Gastroenterol; 2010 Sep; 44(8):e171-7. PubMed ID: 20048685
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting post-embolization fever and liver failure after trans-arterial chemo-embolization in a cohort without background infective hepatitis- a prospective analysis.
Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage CA; Upasena A; Sirigampala C; de Silva HJ
BMC Gastroenterol; 2015 Aug; 15():96. PubMed ID: 26239844
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter arterial chemoembolization confers survival benefit in patients with a spontaneously ruptured hepatocellular carcinoma.
Kim JY; Lee JS; Oh DH; Yim YH; Lee HK
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):640-5. PubMed ID: 22395224
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for the development of pulmonary oil embolism after transcatheter arterial chemoembolization of hepatic tumors.
Wu GC; Chan ED; Chou YC; Yu CY; Hsieh TY; Hsieh CB; Chian CF; Ke FC; Dai YL; Su WL
Anticancer Drugs; 2014 Sep; 25(8):976-81. PubMed ID: 24736105
[TBL] [Abstract][Full Text] [Related]
16. Effect of acute kidney injury on the patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Sohn W; Ham CB; Kim NH; Kim HJ; Cho YK; Jeon WK; Kim BI
PLoS One; 2020; 15(12):e0243780. PubMed ID: 33315944
[TBL] [Abstract][Full Text] [Related]
17. Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test.
Huang YS; Chiang JH; Wu JC; Chang FY; Lee SD
Am J Gastroenterol; 2002 May; 97(5):1223-7. PubMed ID: 12014732
[TBL] [Abstract][Full Text] [Related]
18. Acute kidney injury after platinum-based transcatheter arterial chemoembolization and transarterial infusion chemotherapy in patients with hepatocellular carcinoma.
Hayashi M; Abe K; Fujita M; Okai K; Takahashi A; Ohira H
Jpn J Clin Oncol; 2020 Jan; 50(1):36-43. PubMed ID: 31665483
[TBL] [Abstract][Full Text] [Related]
19. Effect of transcatheter arterial chemoembolization on kidney hemodynamics and function in patients with cirrhosis and hepatocellular carcinoma.
Nakano R; Iwao T; Oho K; Ono N; Sakai T; Sato M; Yamawaki M; Miyamoto Y; Sakai K; Takeda T; Tsuruta O; Sata M; Toyonaga A
J Hepatol; 1999 Aug; 31(2):340-6. PubMed ID: 10453949
[TBL] [Abstract][Full Text] [Related]
20. The influence on liver function after transcatheter arterial chemoembolization combined with percutaneous radiofrequency ablation in patients with hepatocellular carcinoma.
Li JX; Wu H; Huang JW; Zeng Y
J Formos Med Assoc; 2012 Sep; 111(9):510-5. PubMed ID: 23021508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
